Andrew Oleinikov has found that conotoxins found in cone snail venom could potentially treat malaria. The study reflects important advances toward the development of a new, cost-effective drug aimed at counteracting the effects of severe malaria. His work was published in the Journal of Proteomics.
“Molecular stability, small size, solubility, intravenous delivery, and no immunogenic response make conotoxins excellent blockade-therapy candidates,” said Oleinikov. “Further investigation is likely to yield breakthroughs in fields continuously toiling for more efficient therapeutic approaches such as cancer, autoimmune diseases, novel emerging viral diseases as well as malaria.”
View Related Expert Profiles: Go to Source
